Speaking with investors and reporters, officials from Zimmer Holdings, Boston Scientific and Advanced Medical Technology Association, the industry trade group, said they opposed the proposal, which has not yet been written into legislation.
Ray Elliott, president and CEO of Boston Scientific, warned that the fees could lead to job cuts, reduced research and development, and moving company registrations offshore.
Read CNN Money’s report on proposed medical device company fees.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
